2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
作者:Theresa A. McDonagh, Marco Metra, Marianna Adamo, Roy S. Gardner, Andreas Baumbach, Michael C Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel, John G.F. Cleland, María G. Crespo‐Leiro, Dimitrios T. Farmakis, Martine Gilard, Stephane R B Heymans, Arno Wilhelmus Hoes, Tiny Jaarsma, Ewa Anita Jankowska, Mitja Lainščak, Carolyn S.P. Lam, Alexander Richard Lyon, John J.V. McMurray, Alexandre Mebazaa, Richard Mindham, Claudio Muneretto, Massimo Francesco Piepoli, Susanna Price, Giuseppe M.C. Rosano, Frank T. Ruschitzka, Anne Kathrine Skibelund, ESC Scientific Document Group, Rudolf A. de Boer, Paul Christian Schulze, Elena Arbelo, Jozef Bartúnek, Johann K Bauersachs, Michael A Borger, Sergio Buccheri, Elisabetta Cerbai, Erwan Donal, Frank Edelmann, Gloria Färber, Bettina Heidecker, Borja Ibanez, Stefan Karl James, Lars Køber, Konstantinos C Koskinas, Josep Masip, John William McEvoy, Robert John Mentz, Borislava Mihaylova, Jacob Eifer Møller, Wilfried Müllens, Lis Neubeck, Jens Cosedis Nielsen, Agnès Pasquet, Piotr P. Ponikowski, Eva Prescott, Amina Rakisheva, Bianca Rocca, Xavier Rosselló, Leyla Elif Sade, Hannah Schaubroeck, Elena Tessitore, Mariya Petkova Tokmakova, Peter van der Meer, Isabelle C. Van Gelder, Mattias Van Heetvelde, Christiaan J. Vrints, Matthias Wilhelm, Adam Witkowski, Katja Zeppenfeld, Naltin Shuka, Mohammed Chettibi, Hamlet G. Hayrapetyan, Noémi Pávó, Aysel İslamlı, Anne–Catherine Pouleur, Zumreta Kušljugić, Mariya Petkova Tokmakova, Davor Miličić, Theodoros Christodoulides, Filip Málek, Lars Køber, M. Koriem, Pentti Põder, Johan Lassus, François Roubille, Vaja Agladze, Stefan Frantz, Alexia Stavrati, Annamária Kosztin, Inga Jóna Ingimarsdóttir, Patricia M Campbell, Tal Hasin, Fabrizio Giovanni Oliva, Nazipa Aidargaliyeva, Gani Bajraktari, Erkin Mirsaidovich Mirrakhimov, Ginta Kamzola, Ali M El Neihoum, Diana Žaliaduonytė, Alice May Moore, Eleonora Vataman, Aneta Bošković, Mohamed Alami, Olivier Christiaan Manintveld, Elizabeta Srbinovska Kostovska, Kaspar Broch, Jadwiga Nessler, Fátima Franco, Bogdan Alexandru Popescu, Marina Foscoli, Anastazija Stojšić Milosavljević, Eva Gonçalvesová, Zlatko Fras, José González‐Costello, Krister Lindmark, Matthias Paul, Abdulnasser Oudeh, Lilia Zakhama, Ahmet Orhan Celik, Leonid Georgievich Voronkov, Andrew L. Clark, Т. А. Абдуллаев, Eva Prescott, Stefan Karl James, Elena Arbelo, Colin Baigent, Michael A Borger, Sergio Buccheri, Borja Ibanez, Lars Køber, Konstantinos C Koskinas, John William McEvoy, Borislava Mihaylova, Richard Mindham, Lis Neubeck, Jens Cosedis Nielsen, Agnès Pasquet, Amina Rakisheva, Bianca Rocca, Xavier Rosselló, Ilonca C. H. Vaartjes, Christiaan J. Vrints, Adam Witkowski, Katja Zeppenfeld · 发表于:European Heart Journal · 年份:2023 · DOI:10.1093/eurheartj/ehad195 · 被引用次数:2438 · 研究领域:Heart Failure Treatment and Management、Cardiovascular Function and Risk Factors、Diabetes Treatment and Management
1. Preamble 3629 2. Introduction 3631 3. Chronic heart failure 3631 4. Acute heart failure 3634 4.1. Medical therapy 3634 4.1.1. Diuretics 3634 4.1.2. Sodium–glucose co-transporter 2 inhibitors 3634 4.2. Management strategies 3634 4.2.1. Admission phase 3634 4.2.2. Pre-discharge and early post-discharge phases 3634 5. Comorbidities 3635 5.1. Chronic kidney disease and type 2 diabetes mellitus 3635 5.1.1. Sodium–glucose co-transporter 2 inhibitors 3635 5.1.2. Finerenone 3636 5.2. Iron deficiency 3636 6. Data availability statement 3637 7. Author information 3637 8. Appendix 3638 9. References 3638 Recommendation Table 1 — Recommendation for the treatment of patients with symptomatic heart failure with mildly reduced ejection fraction 3633 Recommendation Table 2 — Recommendation for the treatment of patients with symptomatic heart failure with preserved ejection fraction 3633 Recommendation Table 3 — Recommendation for pre-discharge and early post-discharge follow-up of patients hospitalized for acute heart failure 3635 Recommendation Table 4 — Recommendations for the prevention of heart failure in patients with type 2 diabetes mellitus and chronic kidney disease 3636 Recommendation Table 5 — Recommendations for the management of iron deficiency in patients with heart failure 3637 Table 1 Classes of recommendations 3630 Table 2 Levels of evidence 3630 Table 3 Definition of heart failure with reduced ejection fraction, mildly reduced ejection fraction, and preserved ejection fra...